Net Cash Provided by (Used in) Operating Activities |
-258K |
USD |
+19.1% |
Mar 31, 2023 |
Q1 2023 |
Net Cash Provided by (Used in) Investing Activities |
151K |
USD |
|
Mar 31, 2023 |
Q1 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-108K |
USD |
+66.3% |
Mar 31, 2023 |
Q1 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
51.4K |
USD |
-89.7% |
Jun 30, 2023 |
Q2 2023 |
Deferred Tax Assets, Valuation Allowance |
1.32M |
USD |
+383% |
Dec 31, 2022 |
Q4 2022 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Dec 31, 2022 |
2022 |
Deferred Tax Assets, Gross |
1.59M |
USD |
|
Jun 30, 2023 |
Q2 2023 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Jun 30, 2023 |
Q2 2023 |
Deferred Federal Income Tax Expense (Benefit) |
-1.4M |
USD |
-415% |
Dec 31, 2022 |
2022 |
Preferred Stock, Shares Authorized |
1M |
shares |
0% |
Jun 30, 2023 |
Q2 2023 |
Unrecognized Tax Benefits |
0 |
USD |
|
Jun 30, 2023 |
Q2 2023 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Jun 30, 2023 |
Q2 2023 |
Current Federal Tax Expense (Benefit) |
592K |
USD |
|
Dec 31, 2022 |
2022 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Jun 30, 2023 |
Q2 2023 |